Analytic variability in immunohistochemistry biomarker studies. - Wikidata - wikimedia - TriplyDB

Analytic variability in immunohistochemistry biomarker studies.

Analytic variability in immunohistochemistry biomarker studies.

http://www.wikidata.org/entity/Q37479225

about

Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer EGFR soluble isoforms and their transcripts are expressed in meningiomas.Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).Multiplexed ion beam imaging of human breast tumors Detection of the epidermal growth factor receptor, amphiregulin and epiregulin in formalin-fixed paraffin-embedded human placenta tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging.From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancer.Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancer Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades.EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial Cytoplasmic estrogen receptor in breast cancer.EGFR protein expression in non-small cell lung cancer predicts response to an EGFR tyrosine kinase inhibitor--a novel antibody for immunohistochemistry or AQUA technology.Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR.Tumor epidermal growth factor receptor and EGFR PY1068 are independent prognostic indicators for head and neck squamous cell carcinoma.Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.Empirical comparison of color normalization methods for epithelial-stromal classification in H and E images The status of epidermal growth factor receptor in borderline ovarian tumours.Guidelines and considerations for conducting experiments using tissue microarrays.Hormonal treatment in recurrent and metastatic gynaecological cancers: a review of the current literature.Clinical utility of reverse phase protein array for molecular classification of breast cancer.Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissues.PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc.Working towards a consensus for antibody validation.Intrinsic indicators for specimen degradation.Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.How difficult is the validation of clinical biomarkers?Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.Unvalidated antibodies and misleading results.The Challenges of Validating in Precision Medicine: The Case of Excision Repair Cross-Complement Group 1 Diagnostic Testing.In situ protein detection with enhanced specificity using DNA-conjugated antibodies and proximity ligation.A reference image-based method for optimization of clinical immunohistochemistry.Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers

P2860

Q28084216-A388EABB-A2EE-4AF8-95D5-9020DF0FA921 Q31062214-04811261-C375-4489-AEED-158D37F9D7F9 Q33917876-83CB8AC0-F2EB-4512-B45B-9CFA6854DBC8 Q33949706-1C092C30-8CCE-47E0-8253-6DD7C7159203 Q34809415-4EA8512D-A6B3-49B5-8171-5CD26F154DCF Q35117568-64A815A1-6FD7-4C17-BE6B-08D6265F4202 Q35145095-C93D2DE8-E68F-4958-878F-6142078AB0C8 Q35167923-ECC529C8-9294-48E5-98E6-5FED3B2EF60D Q35251561-10B318CD-A507-4486-81DE-F06436BFFE34 Q35440615-FDED9C33-73B2-4700-93FA-33DB25FBDD08 Q35678436-998F97EC-A7F1-4CE8-AEAA-79F57970073E Q35686728-B62028EB-E26C-4405-ABC7-400FC64C26A6 Q35699888-B5BCE4FA-0D88-4962-A5E4-5DCFB169057F Q35844968-86F69C2F-E0EA-4070-8FE6-5B0BF1220AA6 Q36196817-66D0FE1D-F183-40C9-970D-7F02A9E45C5D Q36547753-980CC3B1-3D86-4BD1-990C-C275FBBFBC42 Q36816118-0B4A5F69-D439-4748-AF3C-6677BBFC4964 Q36963030-AB6ECF9C-F09A-4496-9C60-E084C91F3974 Q38106730-9E1DDBAA-07A6-42FD-B7DB-DE956DE85CBB Q38149813-99B5F9A8-E3BD-4D7B-9092-C2317BDE1E0C Q38383140-5D25D74A-2836-485B-BF09-C1A0E267A19F Q38404913-F96E8BE4-9052-4630-B333-2A55546DD612 Q38736925-296A0087-D2C9-4060-9657-2654D2AA18BE Q39061496-2129009F-BA99-40E5-9470-18708787F5E3 Q39232322-F5850622-16DB-4CBB-A694-B94D1EFADF75 Q39358414-9D73B374-46E2-4102-81E1-CD37A417C383 Q39499017-840CEC9E-1D20-4916-8191-1CD6A3AAADEA Q40650002-50D03E6E-31DE-4F1B-B51C-72E7F3CC6973 Q42505561-B3A87E82-D4D1-4C42-8611-64F43E64B692 Q42971341-6FB2A069-B7A3-4D36-BEED-66021C0DD5A0 Q47110861-E74FA62D-B69B-419C-942C-8899A8FDBFC1 Q47762917-64A7439F-3E5D-4F7A-88F4-9D4F5A8BF5CE Q48518220-DC956535-0FD2-4881-8CCA-DBFCE2C2A73A Q55025383-5FC40F66-0E3D-45AC-A6F4-A5DFC2A5DEB2 Q58601441-7471B3D9-8227-49C3-B8B5-A65F82D8C038

P2860

Analytic variability in immunohistochemistry biomarker studies.

http://www.wikidata.org/entity/Q37479225

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analytic variability in immunohistochemistry biomarker studies.

@en

Analytic variability in immunohistochemistry biomarker studies.

@nl

type

label

Analytic variability in immunohistochemistry biomarker studies.

@en

Analytic variability in immunohistochemistry biomarker studies.

@nl

prefLabel

Analytic variability in immunohistochemistry biomarker studies.

@en

Analytic variability in immunohistochemistry biomarker studies.

@nl

P1433

Q37479225-36F457C5-8A6B-4121-AF2A-A05509B7E18C

P1476

Q37479225-8EE0FF22-AF54-400B-86B5-F8E495C430A1

P2093

Q37479225-41E7FC4E-4211-456F-A372-D887390B7CDD

Q37479225-7230124C-3A79-425B-8E6D-7C3542E7A8DA

Q37479225-79C14A44-1902-493B-AA85-B516E7615744

Q37479225-7BAC1677-D0B6-443F-AFCE-D04AA4112F6B

Q37479225-8063A8C5-157D-42EB-90A8-94BB666FE733

Q37479225-8E6A5376-AD10-4568-A72D-0B8A45497C89

Q37479225-EC1868F7-3A74-43A8-9772-D683E2915EB2

Q37479225-FCEF732F-E91B-414F-A73C-6073B58D4F59

P2860

Q37479225-05790E54-B47F-4D5F-8C84-93C4AA0E9C12

Q37479225-0C04C5C4-1B6E-48F9-A0A7-1C04E100C68C

Q37479225-1173F661-AD29-4A82-AAAA-32F4E063DBC1

Q37479225-374A3D03-BC49-4560-9E61-94668FACD262

Q37479225-37891B18-4322-47F1-BCA9-A943314BA23B

Q37479225-387EEDDF-18FB-4558-9A8C-4046B7DD31D1

Q37479225-3B0C697D-C8DD-4A9B-97BF-23B3AE0B7697

Q37479225-3E357C2C-4928-4094-8953-432D55A09954

Q37479225-45A7EF60-20D4-424E-9F8E-964A77D3C351

Q37479225-478CA1E6-A0D0-4349-A535-A0A684AC4830

P304

Q37479225-41DDFD66-DB75-4CCC-A4C1-A091DD99AB5A

P31

Q37479225-339056FC-5DEB-4F6F-B6A3-47D9AF15566B

P356

Q37479225-54C5507F-6A19-462A-933B-7C5A5B66F3AC

P433

Q37479225-62F33B25-A05A-4B20-8EED-3392FEB0A68C

P478

Q37479225-740934F3-BC53-4F61-BF33-E53FA0F5800E

P50

Q37479225-54FD65F9-1E32-4162-A7CF-21B715B75297

P577

Q37479225-D3A0D64D-7AD2-466C-8BED-0ECA00A9A90D

P698

Q37479225-FC9D8296-163F-47FB-9F79-C44A9DD837E2

P921

Q37479225-185EEBE2-5A37-49E3-B57F-C8517F914C03

Q37479225-651D4AFE-204F-40FD-AC93-8BDDB09E809A

P932

Q37479225-7E683096-9BDE-4C62-A328-96E88AA60B7F

P356

1055-9965.EPI-10-0097

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Analytic variability in immunohistochemistry biomarker studies

@en

P2093

Allison W Welsh

http://www.w3.org/2001/XMLSchema#string

Camil Liceaga

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Jennifer M Giltnane

http://www.w3.org/2001/XMLSchema#string

Konstantinos N Syrigos

http://www.w3.org/2001/XMLSchema#string

Mark Gustavson

http://www.w3.org/2001/XMLSchema#string

Summar Siddiqui

http://www.w3.org/2001/XMLSchema#string

Valsamo K Anagnostou

http://www.w3.org/2001/XMLSchema#string

P2860

Untangling the ErbB signalling network

Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE)

The taming of immunohistochemistry: the new era of quality control.

Evaluation of alpha-synuclein immunohistochemical methods used by invited experts

Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of

Overview of the clinical immunohistochemistry laboratory: regulations and troubleshooting guidelines.

A practical approach for evaluating new antibodies in the clinical immunohistochemistry laboratory.

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Commercial antibodies: the good, bad, and really ugly.

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis.

P304

982-991

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-10-0097

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20332259

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

3891912

http://www.w3.org/2001/XMLSchema#string